Inhibiting S100B(ββ) for activating wild-type p53 : design of stapled peptides
S100B(ββ) is a member of the S100B protein family and is distributed in a cell-specific manner. Its levels are elevated in several cancers such as malignant melanoma and correlate directly with poor prognosis in patients. S100B(ββ) directly interacts with the tumor suppressor p53, inhibiting tetrame...
Main Authors: | Kannan, Srinivasaraghavan, Aronica, Pietro G. A., Tan, Yaw Sing, Verma, Chandra Shekhar |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Journal Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/137422 |
Similar Items
-
Computational Design of Macrocyclic Binders of S100B(ββ): Novel Peptide Theranostics
by: Srinivasaraghavan Kannan, et al.
Published: (2021-01-01) -
Computational design of macrocyclic binders of S100B(ββ): novel peptide theranostics
by: Kannan, Srinivasaraghavan, et al.
Published: (2022) -
Molecular descriptors suggest stapling as a strategy for optimizing membrane permeability of cyclic peptides
by: Li, Jianguo, et al.
Published: (2022) -
Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides
by: Verma, Chandra Shekhar, et al.
Published: (2019) -
The nanotube express: delivering a stapled peptide to the cell surface
by: Holdbrook, Daniel A., et al.
Published: (2022)